Experienced in Cholestasis

Marcel S. Vetter

Erlangen, BY, DE 
Experienced in Cholestasis
Erlangen, BY, DE 
OverviewLocationsClinical Research

Overview

Marcel Vetter practices in Erlangen, Germany. Mr. Vetter is rated as an Experienced expert by MediFind in the treatment of Cholestasis. His top areas of expertise are Primary Biliary Cholangitis, Cholestasis, Cholangitis, Endoscopy, and Colonoscopy.

His clinical research consists of co-authoring 34 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles and participated in 2 clinical trials in the study of Cholestasis.

Gender
Male

Locations

Erlangen, BY, Germany
Other Locations
Bayern, BY, Germany
Bayreuth, BY, Germany
Alexander, NW, Germany
Mainz, RP, Germany
Heidelberg, BW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Two-part, Randomized, Placebo Controlled, Double Blind, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis (PBC)
A Two-part, Randomized, Placebo Controlled, Double Blind, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis (PBC)
Enrollment Status: Completed
Publish Date: July 22, 2025
Intervention Type: Drug
Study Drug: Linerixibat
Study Phase: Phase 3
Long-term Safety and Tolerability Study of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis
Long-term Safety and Tolerability Study of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis
Enrollment Status: Active_not_recruiting
Publish Date: July 18, 2025
Intervention Type: Drug
Study Drug: Linerixibat
Study Phase: Phase 3
View 1 Less Clinical Trial

34 Total Publications

Ultrasound derived fat fraction indicates reduction of liver fat content after lifestyle modification in obese patients.
Ultrasound derived fat fraction indicates reduction of liver fat content after lifestyle modification in obese patients.
Journal: Clinical hemorheology and microcirculation
Published: September 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Vetter's expertise for a condition
ConditionClose
        View All 20 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile